Kochański A
Neuromuscular Unit, Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
Acta Myol. 2004 May;23(1):6-9.
Initially the Myelin Protein Zero gene was shown to be mutated in the demyelinating form of Charcot-Marie-Tooth disease (CMT1). The vast majority of the mutations in the Myelin Protein Zero gene have been detected in the Charcot-Marie-Tooth (1B) disease, however, some of them were found in patients suffering from congenital hypomyelinating neuropathy and axonal type Charcot-Marie-Tooth disease. In this study, a Charcot-Marie-Tooth disease phenotype diversity associated with different mutations in the MPZ gene, is described.
最初,髓磷脂蛋白零基因被证明在脱髓鞘型夏科-马里-图斯病(CMT1)中发生突变。髓磷脂蛋白零基因的绝大多数突变已在夏科-马里-图斯(1B)病中被检测到,然而,其中一些突变也在患有先天性髓鞘形成不足性神经病和轴索性夏科-马里-图斯病的患者中被发现。在本研究中,描述了与MPZ基因不同突变相关的夏科-马里-图斯病表型多样性。